. . . Without Promoting Conflicts Of Interest?

An issue that has received almost no attention in the debate about university-industry partnerships reaches beyond the norms of science and the mission of the university. I am referring to the importance to society of an independent academic sector. Professors are frequently called on to provide technical expertise and to exercise independent judgment across the range of public policy. Scientists serve on a host of public advisory committees and risk assessment panels at all levels of governme

Written bySheldon Krimsky
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

An issue that has received almost no attention in the debate about university-industry partnerships reaches beyond the norms of science and the mission of the university. I am referring to the importance to society of an independent academic sector.

Professors are frequently called on to provide technical expertise and to exercise independent judgment across the range of public policy. Scientists serve on a host of public advisory committees and risk assessment panels at all levels of government. Every regulatory and funding agency depends on the use of outside experts. For this process to work effectively in our highly complex technological society, it is essential that we secure unbiased, objective advice from individuals who are financially disinterested in the areas in which they are called on to consult. To take an admittedly hypothetical example, if every nuclear scientist in the academic world were on the payroll of the nuclear industry, where, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies